Neuro-All January 2017

neuro-all@lists.umanitoba.ca

1 participants
5 discussions

Reminder - Public lecture this evening....

by networking＠manitobaneuroscience.ca

Public Seminar: What Can Brain Imaging Tell Us About Dementia? Presented by leading radiologist Dr. Marco Essig MD, PhD, FRCPC Thursday, January 26 7 - 8:30 pm Samuel N. Cohen Auditorium St-Boniface Hospital Albrechtsen Research Centre Brain imaging can be used to detect changes related to mild cognitive impairment, Alzheimer's dementia, frontotemporal dementia, vascular dementia and Lewy body dementia. Come to hear how information learned from brain imaging can assist in the diagnosis and treatment of dementia. https://7258.thankyou4caring.org/pages/january-education-2017 Space is limited! Register online at alzheimer.mb.ca For more information: Call 204-943-6622 or email alzmb(a)alzheimer.mb.ca <mailto:alzmb@alzheimer.mb.ca> ****************************************** <http://www.manitobaneuroscience.ca/> <https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>

7 years, 2 months

FW: MNN Visiting Speaker & Seminar Series - Dr. Chase Figley Jan 27 @ 9am

by networking＠manitobaneuroscience.ca

Visiting Speaker & Seminar Series Friday, January 27th, 2017 9:00 a.m. PX236/238 PsychHealth Bldg., Bannatyne Campus Dr. Chase Figley Assistant Professor - Department of Radiology, University of Manitoba Principal Investigator - Neuroscience Research Program Core Member - Biomedical Engineering Graduate Program, University of Manitoba Adjunct Assistant Professor - Department of Physiology & Pathophysiology, University of Manitoba Adjunt Assistant Professor - Department of Psychology, University of Manitoba Adjunct Research Scientist - Department of Psychological & Brain Sciences, Johns Hopkins University What's new in human neuro-imaging? Recent advances in MRI acquisition, analysis, and applications BIO: Chase Figley is currently an Assistant Professor in the Department of Radiology at the University of Manitoba and a Principal Investigator within the Neurosci-ence Research Program at the Kleysen Institute for Advanced Medicine. In addition, he also holds adjunct appoint-ments in Biomedical Engineering (University of Manitoba), Diagnostic Imaging (Winnipeg Health Sciences Centre), and the Department of Psycho-logical & Brain Sciences (Johns Hopkins University). Before moving to Winnipeg in September 2013, he completed a BSc (Honors) in Chemistry at the University of Saskatchewan (2001-2005), a PhD in Neuroscience at Queen's University (2005-2010), and a CIHR-sponsored Postdoctoral Fellowship at Johns Hopkins University (2010-2013). The ongoing research in his lab is primarily focused on developing and applying advanced neuroimaging methods - e.g., functional MRI (fMRI), diffusion tensor imaging (DTI), myelin water imaging (MWI), and voxel based morphometry (VBM) - to study brain structure and function in both healthy and clinical populations. ABSTRACT: Despite major advances in our ability to characterize white matter microstructure with novel acquisition methods like diffusion tensor imaging (DTI) and Myelin Water Imaging (MWI), these improvements have not yet translated into better diagnostic or prognostic capabilities in Multiple Sclerosis (MS) or other white matter disorders. In other words, more sophisticated data acquisition methods alone have not overcome the well-known "clinico-radiological paradox" (i.e., where imaging biomarkers such as lesion count, lesion volume, etc. do not accurately or reliably predict patients' clinical outcomes). Fortunately, our knowledge about how the brain is organized into large-scale functional networks offers a number of clues about how these problems might be dealt with using more sophisticated data analysis approaches. In this talk, I will briefly discuss the organization and topology of these networks in order to suggest that the locations of white matter lesions - as opposed to the total number or overall volume, per se - are likely what underlie specific functional deficits. I will then proceed to describe two new data analysis approaches that my lab has been working on to: 1) ascribe local white matter changes to specific functional brain networks, and 2) detect and measure local white matter changes along white matter tracts. Finally, I will close by presenting a few recent examples of how these methods have already been used to study structure-function relationships throughout the brain, and how white matter alterations in these regions are correlated with individual differences in body composition and other neuroimaging biomarkers in MS. /sent on behalf of Dr. Eftekhar Eftekharpour Coordinator - MNN Visiting Speaker & Seminar Series Program eftekhar.eftekharpour(a)umanitoba.ca <mailto:eftekhar.eftekharpour@umanitoba.ca> ****************************************** <http://www.manitobaneuroscience.ca/> <https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>

7 years, 2 months

MNN Visiting Speaker - Dr. James Eubanks Friday Feb 10th

by networking＠manitobaneuroscience.ca

Please mark your calendars..... Visiting Speaker & Seminar Series Friday, February 10, 2017 12:00 NOON. Apotex Theatre 071, Bannatyne Campus Dr. James Eubanks Senior Scientist - Krembil Research Institute Professor - Department of Surgery, University of Toronto Enhancing Excitation To Combat Lost Silencing: Therapeutic Considerations For Rett Syndrome ***FOLLOWED BY A "NEUROSCIENCE TRAINEE LUNCH" IN SR415 Kleysen Bldg. BIO: The primary interests of my group relate to defining how the absence of either methyl DNA binding factor MeCP2, or more recently CDKL5, affects normal brain function and/or alters the normal progression of brain development, and to identifying strategies that can be used to correct the observed alterations. Our work encompasses generating novel transgenic mouse lines that can be used to address questions relating to our focus, to testing novel pharmacological agents in established models of Rett syndrome as part of translational efforts. We are well positioned to assess therapeutically meaningful endpoints for the translational studies, and have the skills needed to identify key deficits that can then be subsequently targeted. It is our intention to identify novel strategies that can someday be employed to treat patients with Rett syndrome, with the ultimate goal being condition correction. Our current investigations span several research disciplines, including cell biology, pharmacology, electrophysiology, molecular genetics, animal behavior, and live cell imaging. /sent on behalf of Dr. Eftekhar Eftekharpour Coordinator - MNN Visiting Speaker & Seminar Series Program eftekhar.eftekharpour(a)umanitoba.ca <mailto:eftekhar.eftekharpour@umanitoba.ca> ****************************************** <http://www.manitobaneuroscience.ca/> <https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>

7 years, 2 months

Dementia Public Seminar

by networking＠manitobaneuroscience.ca

/sent on behalf of Dr. Ben Albensi What Can Brain Imaging Tell Us About Dementia? Public Seminar Thursday, January 26, 2017 7 - 8:30 pm Samual N. Cohen Auditorium St-Boniface Hospital Albrechtsen Research Centre Sponsored by the Alzheimer's Society of Manitoba https://7258.thankyou4caring.org/pages/january-education-2017 ****************************************** <http://www.manitobaneuroscience.ca/> <https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>

7 years, 2 months

Opportunity for a graduate student

by networking＠manitobaneuroscience.ca

There is a sustained effort being made by the Canadian local chapters of the Society for Neuroscience to meet regularly to discuss activities and opportunities. The first meeting was held at the recent SFN conference in San Diego and the next get-together will be at the Canadian Association for Neuroscience meeting in Montreal this May. The Chapters agreed that we would like to involve student members at the next meeting so I am looking for a PhD student with a strong interest in neuroscience networking, outreach and education to represent the MNN in Montreal. If you plan to attend the 2017 CAN meeting and are interested in this opportunity, please reply to this message. There may be an opportunity for a travel award to offset some of the travel expenses. Thank you. Chris Anderson MNN President ****************************************** <http://www.manitobaneuroscience.ca/> <https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>

7 years, 3 months

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

Neuro-All January 2017